MedPath

Body composition assessment in children with Acute Lymphoblastic Leukaemia (ALL) during cancer treatment

Not Applicable
Conditions
Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]
Registration Number
CTRI/2019/11/022181
Lead Sponsor
International Atomic Energy Agency
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Newly detected cases of children with acute lymphoblastic leukaemia

Age range 2-8 years

Normal healthy children in the age of 2 to 8 as control subjects

Exclusion Criteria

Conditions such as diabetes, hormonal problems which could affect body composition

Children with sepsis causing hemodynamic compromise and who cannot be assessed.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath